Search
-
Assessing post-pandemic stickiness of product subscriptions
Product subscriptions have gained a new relevance during the pandemic, but will this behavior stick in a post COVID-19 world?
-
Americans want the government to shop domestically, no matter the price
Americans agree the U.S. government should buy U.S.-made products even if they are more expensive but don’t necessarily hold themselves to the same standard.
-
Two in five Americans admit that they have purchased chocolate milk for someone in their household that they ended up drinking
New Organic Valley/Ipsos poll finds that two thirds agree enjoying chocolate milk is a healthy way to indulge during COVID-19
-
App-based takeout surged during the pandemic. But did it drive new business, or reinforce what was already there?
Food delivery surged during the pandemic – especially third-party delivery services. Here’s how Americans used those apps.
-
Three-quarters approve of Biden’s coronavirus vaccine response
New ABC News/Ipsos poll finds widespread approval on COVID-19 issues, but most disapprove of how he’s handling the situation at the border
-
Cliff’s Take: Guns, Immigration and Race—Have We Come Full Circle?
Intractable societal issues loom in background despite new optimism about the end of the pandemic.
-
Get Ready for the Big Reset in Travel
The next wave in travel is just around the corner. Companies need to prepare now to catch customers at the right time with an eye on turning them into loyal advocates.
-
Income inequality is seen as the most serious form of disparity both in the U.S. and globally
U.S. shows second-highest level of concern about race and ethnicity-based inequality among 28 countries surveyed
-
[WEBINAR] Affluent Americans: Surviving, Reviving & Thriving
As more and more Americans are getting vaccinated, the long awaited return to “normal” is on the horizon.
-
[WEBINAR] Physician-Administered Therapies: Access Strategies & Insights
Join Ipsos for a complimentary webinar as we explore the expected evolution of the access and reimbursement environment for physician-administered therapies, and outline what it means for you as you prepare to launch physician-administered therapies.